Click here to download a complimentary copy of Hedge Fund Solutions' Catalyst Investment Research report for Penwest Pharmaceuticals Co. (Ticker: PPCO).
This professional grade research is dedicated to uncovering undervalued publicly traded companies that could have the potential to generate outsized returns due to an activist investors involvement.
Annual subscriptions are now available (a minimum of 24 research reports per year).
Email: email@example.com if you are interested in subscription information.
Hedge Fund Solutions, LLC is not an investment, legal, or tax advisor, and none of the information available through the Firm is intended to provide tax, legal or investment advice.